John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Alpha Teknova
TKNO
$388M
| $50.1K | ﹤0.01% |
+10,359
| New | +$38.2K |
|
|
CRDL
2927
Cardiol Therapeutics
CRDL
$208M
| $48.8K | ﹤0.01% |
+24,666
| New | +$51.2K |
|
2928
NET Power Inc Warrants
NPWR.WS
$26.2M
| $48.1K | ﹤0.01% |
41,085
| – | – |
|
2929
Rafael Holdings
RFL
$112M
| $47.8K | ﹤0.01% |
25,008
-1,803
| -7% | -$2.7K |
|
2930
Ribbon Communications
RBBN
$359M
| $46.7K | ﹤0.01% |
14,359
-19,447
| -58% | -$63.1K |
|
|
RSVRW
2931
DELISTED
Reservoir Media Inc Warrant
RSVRW
| $43.4K | ﹤0.01% |
32,400
| – | – |
|
|
LUMO
2932
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $43.1K | ﹤0.01% |
11,130
-7,815
| -41% | -$21.6K |
|
2933
Newegg Commerce
NEGG
$392M
| $42.8K | ﹤0.01% |
+2,893
| New | +$49.5K |
|
2934
Pixelworks
PXLW
$41.7M
| $41.2K | ﹤0.01% |
4,832
+859
| +22% | +$8.5K |
|
2935
Precigen
PGEN
$2.49B
| $40.9K | ﹤0.01% |
43,159
-5,156
| -11% | -$6.5K |
|
2936
Creative Medical Technology
CELZ
$8.31M
| $40.6K | ﹤0.01% |
13,106
-1,703
| -11% | -$5.77K |
|
2937
Citizens
CIA
$192M
| $39.6K | ﹤0.01% |
10,935
-2,265
| -17% | -$6.62K |
|
2938
ThredUp
TDUP
$369M
| $38.6K | ﹤0.01% |
45,842
-53,659
| -54% | -$65.6K |
|
|
ALLK
2939
DELISTED
Allakos
ALLK
| $38.6K | ﹤0.01% |
+59,089
| New | +$42.8K |
|
2940
HeartCore Enterprises
HTCR
$4.05M
| $37.5K | ﹤0.01% |
2,204
| – | – |
|
2941
InflaRx
IFRX
$304M
| $36.7K | ﹤0.01% |
24,013
-27,528
| -53% | -$41.9K |
|
2942
Ampco-Pittsburgh
AP
$186M
| $35.5K | ﹤0.01% |
+17,769
| New | +$29.8K |
|
|
WHWK
2943
Whitehawk Therapeutics
WHWK
$268M
| $34.8K | ﹤0.01% |
+16,917
| New | +$27.3K |
|
2944
iPower
IPW
$542K
| $34.8K | ﹤0.01% |
+9
| New | +$29.8K |
|
2945
GigaMedia
GIGM
$15.9M
| $34.7K | ﹤0.01% |
24,123
+3
| +0% | +$4 |
|
|
CARM
2946
DELISTED
Carisma Therapeutics
CARM
| $33.5K | ﹤0.01% |
+34,141
| New | +$37K |
|
2947
Akebia Therapeutics
AKBA
$247M
| $32.8K | ﹤0.01% |
+24,848
| New | +$33.2K |
|
2948
Goldgroup Mining
GORO
$249M
| $32.6K | ﹤0.01% |
93,325
+333
| +0.4% | +$131 |
|
|
OTLY
2949
Oatly Group
OTLY
$484M
| $32.5K | ﹤0.01% |
1,901
+560
| +42% | +$10.5K |
|
2950
FibroBiologics
FBLG
$9.72M
| $32.3K | ﹤0.01% |
+523
| New | +$34.8K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.